IP Verse

Methods For Treating Skin Infection By Administering An Il-4R Antagonist

Patent No. EP3110848 (titled "Methods For Treating Skin Infection By Administering An Il-4R Antagonist") was filed by Regeneron Pharmaceuticals on Feb 26, 2015. The application was issued on Feb 14, 2024.

Patent Summary

Patent Family

Patent Family

Patent Oppositions (6)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
HAMPTON KNOWLESNov 14, 2024D YOUNG
LUIGINov 14, 2024TER MEER STEINMEISTER & PARTNER
BOEHMERT & BOEHMERT ANWALTSPARTNERSCHAFT MBBNov 13, 2024ENGELHARD
DORRIESNov 13, 2024DORRIES
DORRIESNov 13, 2024DORRIES, HANS ULRICH , DF-MP DORRIES FRANK-MOLNIA & POHLMAN
SECERNANov 13, 2024SECERNA

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP3110848

REGENERON PHARMACEUTICALS
Application Number
EP15710650A
Filing Date
Feb 26, 2015
Status
Granted And Under Opposition
Jan 12, 2024
Publication Date
Feb 14, 2024
External Links
Slate, Register , Google Patents